Framework Agreement for the Provision of High-Tech Home Delivery service for Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies
A Contract Award Notice
by UNIVERSITY HOSPITALS OF DERBY AND BURTON NHS FOUNDATION TRUST
- Source
- Find a Tender
- Type
- Framework (Services)
- Duration
- 2 year (est.)
- Value
- £3M
- Sector
- HEALTH
- Published
- 16 Apr 2025
- Delivery
- 01 May 2025 to 30 Apr 2027 (est.)
- Deadline
- n/a
Concepts
Location
East Midlands
3 buyers
6 suppliers
- Alcura Healthcare Northampton
- Healthnet Homecare Swadlincote
- B Braun Medical Sheffield
- Sciensus Pharma Services Burton on Trent
- Pharmaxo Pharmacy Services Corsham
- Lloydspharmacy Clinical Homecare Harlow
Description
The East Midlands Pharmacy Collaborative (EMPC) (the "Authority") is issuing this Invitation to Tender ("ITT") in connection with the competitive procurement for the Provision of a High-Tech Home Delivery Service for Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies (SACT).
Total Quantity or Scope
This Tender will review the use of Parenteral Chemotherapy (plus associated therapies) and for Parenteral Biologics Inc. Immunotherapies within the East Midlands and look to provide a cost/service improvement through an Open Tender process. This contract outlines the provision of a dispensing/compounding and delivery service to patients’ homes for Parenteral Chemotherapy plus associated treatments and for Parenteral Biologics plus nursing support where required, for administration for all products
Award Detail
1 | Alcura Healthcare (Northampton)
|
2 | Healthnet Homecare (Swadlincote)
|
3 | B Braun Medical (Sheffield)
|
4 | Sciensus Pharma Services (Burton on Trent)
|
5 | Pharmaxo Pharmacy Services (Corsham)
|
6 | Lloydspharmacy Clinical Homecare (Harlow)
|
Award Criteria
Quality | 60.0 |
Price and Value | 40.0 |
CPV Codes
- 85100000 - Health services
Indicators
- Award on basis of price and quality.
Other Information
This is a Provider Selection Regime (PSR) Intention to Award Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt the provisions of the Public Contract Regulations 2015 do not apply to this award.This Contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.No Conflicts of Interest have been declared by any individual involved in this Tender and has been recorded on the Conflict of Interest register accordinglyThe Tender panel was members of the EastMidlands Pharmacy Collaborative Procurement Team and the Homecare Leads from the member Purchasing Authorities.Quality and Innovation 25%Improving access, reducing health inequalities and facilitating choice 15%Integration, collaboration and Service Sustainability10%Social Value & Sustainability 10%Quality Total - 60%Value Total - 10%Price - 30%Total - 100% This is a Provider Selection Regime (PSR) Intention to Award Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt the provisions of the Public Contract Regulations 2015 do not apply to this award.This Contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.No Conflicts of Interest have been declared by any individual involved in this Tender and has been recorded on the Conflict of Interest register accordinglyThe Tender panel was members of the EastMidlands Pharmacy Collaborative Procurement Team and the Homecare Leads from the member Purchasing Authorities.Quality and Innovation 25%Improving access, reducing health inequalities and facilitating choice 15%Integration, collaboration and Service Sustainability10%Social Value & Sustainability 10%Quality Total - 60%Value Total - 10%
Reference
- FTS 015430-2025